Nao-hiro Kawamura

  • Citations Per Year
Learn More
BACKGROUND & AIMS Although a low plasma level of branched-chain amino acids (BCAAs) is a marker of cirrhosis, it is not clear whether BCAA supplements affect disease progression. We performed a multicenter study to evaluate the effects of BCAA supplementation on hepatocarcinogenesis and survival in patients with cirrhosis. METHODS We enrolled 299 patients(More)
  • 1